Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation.
about
Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.Comparison of Dabigatran vs. Warfarin in Acute Vnous Thromboemboly: Systematic Review.Distribution characteristics and factors influencing oral warfarin adherence in patients after heart valve replacement
P2860
Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Warfarin versus dabigatran ete ...... ents with atrial fibrillation.
@en
type
label
Warfarin versus dabigatran ete ...... ents with atrial fibrillation.
@en
prefLabel
Warfarin versus dabigatran ete ...... ents with atrial fibrillation.
@en
P2860
P1476
Warfarin versus dabigatran ete ...... ients with atrial fibrillation
@en
P2093
Gregory Yh Lip
P2860
P356
10.1517/14740338.2015.973847
P407
P577
2014-10-24T00:00:00Z